Clover Health Investments CorpReported profit and raised 2026 guidance, indicating improved financial performance.

Clover Health Investments reported second-quarter 2026 revenue of US$743.17 million, up from US$477.62 million a year earlier, and swung to net income of US$28 million from a net loss of US$10.58 million. The company also raised its full-year 2026 guidance, now projecting total revenues of US$2.92 billion to US$3.00 billion and GAAP net income of US$20 million to US$35 million. Management attributed the improved performance to strong Medicare Advantage membership growth and benefits from its AI-powered Clover Assistant platform. The company's narrative projects US$4.2 billion revenue and US$73.3 million earnings by 2029, implying 18.9% yearly revenue growth.
Clover Health Investments CorpReported profit and raised 2026 guidance, indicating improved financial performance.